Piperaquine pharmacokinetics during intermittent preventive treatment for malaria in pregnancy

Piperaquine pharmacokinetics during intermittent preventive treatment for malaria in pregnancy

Dihydroartemisinin-piperaquine (DP) is a long-acting artemisinin combination treatment that provides effective chemoprevention and has been proposed as an alternative antimalarial drug for intermittent preventive therapy in pregnancy (IPTp). Several pharmacokinetic studies have shown that dose adjus...

Full description

Bibliographic Details
Main Authors:	Chotsiri, P, Gutman, J, Ahmed, R, Poespoprodjo, JR, Syafruddin, D, Khairallah, C, Asih, PBS, L'lanziva, A, Otieno, K, Kariuki, S, Ouma, P, Were, V, Katana, A, Price, RN, Desai, M, Ter Kuile, FO, Tarning, J
Format:	Journal article
Language:	English
Published:	American Society for Microbiology 2021

Similar Items

Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin–piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial
by: Ahmed, R, et al.
Published: (2019)

Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials
by: Julie R Gutman, et al.
Published: (2021-11-01)

Impact of dolutegravir-based antiretroviral therapy on piperaquine exposure following dihydroartemisinin-piperaquine intermittent preventive treatment of malaria in pregnant women living with HIV
by: Banda, CG, et al.
Published: (2022)

Risk of adverse pregnancy outcomes in women treated for malaria with dihydroartemisinin-piperaquine or quinine in the first trimester of pregnancy in Indonesia: a retrospective data analysis
by: Ahmed, R, et al.
Published: (2019)

Healthcare provider and pregnant women’s perspectives on the implementation of intermittent screening and treatment with dihydroartemisinin–piperaquine for malaria in pregnancy in western Kenya: a qualitative study
by: Jenna Hoyt, et al.
Published: (2021-06-01)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
by: Chotsiri, P, et al.
Published: (2017)

Quantification of the antimalarial piperaquine in plasma.
by: Tarning, J, et al.
Published: (2008)

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
by: Mwayiwawo Madanitsa, et al.
Published: (2016-09-01)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Chotsiri, P, et al.
Published: (2019)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
by: Hanboonkunupakarn, B, et al.
Published: (2014)

Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya.
by: Jenny Hill, et al.
Published: (2013-01-01)

Pitfalls in estimating piperaquine elimination.
by: Tarning, J, et al.
Published: (2005)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
by: Byakika-Kibwika, P, et al.
Published: (2019)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
by: Zongo, I, et al.
Published: (2014)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Palang Chotsiri, et al.
Published: (2019-01-01)

Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia
by: Rahmasari, FV, et al.
Published: (2023)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
by: Pauline Byakika-Kibwika, et al.
Published: (2019-12-01)

Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women
by: Jenna Hoyt, et al.
Published: (2018-09-01)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
by: Tarning, J, et al.
Published: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
by: Issaka Zongo, et al.
Published: (2014-01-01)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

Characterization of human urinary metabolites of the antimalarial piperaquine.
by: Tarning, J, et al.
Published: (2006)

Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia
by: Devine, A, et al.
Published: (2017)

Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
by: Badara Cisse, et al.
Published: (2009-09-01)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
by: Tarning, J, et al.
Published: (2008)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
by: Tarning, J, et al.
Published: (2007)

Therapeutic response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia
by: Poespoprodjo, JR, et al.
Published: (2018)

A RANDOMISED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF TWO DIFFERENT DOSING REGIMENS OF DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF ADULTS AT HIGH RISK OF MALARIA IN THAILAND
by: Lwin, K, et al.
Published: (2010)

Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment
by: Leang, R, et al.
Published: (2015)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
by: Permala, J, et al.
Published: (2017)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
by: Bergstrand, M, et al.
Published: (2014)

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
by: Poespoprodjo, J, et al.
Published: (2015)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
by: Phuc, B, et al.
Published: (2017)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
by: Adam, I, et al.
Published: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
by: Adam, I, et al.
Published: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
by: Tarning, J, et al.
Published: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
by: Tarning, J, et al.
Published: (2012)

Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
by: Roland Nnaemeka Okoro, et al.
Published: (2023-01-01)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
by: Jeanne Rini Poespoprodjo, et al.
Published: (2014-01-01)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
by: Tarning, J, et al.
Published: (2008)